Early-Stage Lung Cancer Surgery vs. Radiation Therapy Comparison Request More Information Trial Objective The purpose of this study is to gather information about treatment of early-stage lung cancer in order to compare the effectiveness of surgery versus radiation therapy, potentially improving outcomes for patients with early-stage lung cancer. Enrollment This trial is active and currently recruiting. Who Can Participate Adults who have been diagnosed with early-stage lung cancer are eligible to participate. Age: 18+ Gender: Any Gender Estimated Time Commitment 4 hours, 45 mins. (1) First interview – in person, 90 minutes, (2) interview at seven days – by phone, 30 minutes; (3) interview at 30 days – phone, 30 minutes; (4) interview at three months – phone, 30 minutes; (5) interview at six months – in person, 45 minutes; (6) interview at 12 months – in person, 60 minutes. Total time commitment is four hours and 45 minutes. × Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit. Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study. Payment & Reimbursement Payment: Provided Travel Reimbursement: Not Available Trial Contact For more information, contact: Cole Waliczek 303.270.2844 Request More Information Trial Location National Jewish Main Campus and Saint Joseph Hospital, Denver, CO Trial Sponsors National Cancer Institute Principal Investigators Jeffrey Kern, MD + × Jeffrey Kern, MD Chief, Division of Oncology, Cancer Center Director, Lung Cancer Center Vice Chair, Finance Professor Department of Medicine View Full Profile Patient Rating 5 out of 5 stars Make an Appoinment Request More Information First Name:* Last Name:* Email Address:* Phone:*
Trial Objective The purpose of this study is to gather information about treatment of early-stage lung cancer in order to compare the effectiveness of surgery versus radiation therapy, potentially improving outcomes for patients with early-stage lung cancer.